Fresenius Medical Care Stock Performance
| FMS Stock | USD 23.39 0.31 1.31% |
The firm shows a Beta (market volatility) of 0.85, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fresenius Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fresenius Medical is expected to be smaller as well. At this point, Fresenius Medical Care has a negative expected return of -0.0888%. Please make sure to confirm Fresenius Medical's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Fresenius Medical Care performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Fresenius Medical Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Fresenius Medical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (1.31) | Five Day Return (2.26) | Year To Date Return 5.6 | Ten Year Return (45.32) | All Time Return 121.5 |
Forward Dividend Yield 0.0337 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.79 | Dividend Date 2025-06-06 |
1 | Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement | 10/01/2025 |
2 | Heres Why Fresenius is a Strong Value Stock | 10/16/2025 |
3 | Fresenius Medical Care AG Co. KGaA FMS Shares Sold by Koss Olinger Consulting LLC | 10/28/2025 |
4 | Fresenius Medical Care gives Q3 numbers | 11/04/2025 |
5 | Is Fresenius Medical Care a Bargain After Recent Regulatory News and Share Price Drop | 11/05/2025 |
6 | Fresenius How Does Its Current Valuation Stack Up After This Years Strong Share Price Rally | 11/07/2025 |
7 | Why Fresenius is a Top Value Stock for the Long-Term | 11/10/2025 |
8 | Germanys economic sentiment stalls as policy doubts deepen | 11/11/2025 |
9 | Rehabilitation Therapy Services Market to Surpass USD 64.3 Billion by 2034, Driven by Rising Chronic Diseases and Technological Advancements | 11/12/2025 |
10 | Midwest Trust Co Makes New Investment in Fresenius Medical Care AG Co. KGaA FMS | 11/13/2025 |
| Begin Period Cash Flow | 1.4 B | |
| Total Cashflows From Investing Activities | -84.9 M |
Fresenius | Build AI portfolio with Fresenius Stock |
Fresenius Medical Relative Risk vs. Return Landscape
If you would invest 2,498 in Fresenius Medical Care on August 19, 2025 and sell it today you would lose (159.00) from holding Fresenius Medical Care or give up 6.37% of portfolio value over 90 days. Fresenius Medical Care is generating negative expected returns assuming volatility of 1.6635% on return distribution over 90 days investment horizon. In other words, 14% of stocks are less volatile than Fresenius, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Fresenius Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fresenius Medical Care, and traders can use it to determine the average amount a Fresenius Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0534
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FMS |
Estimated Market Risk
| 1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fresenius Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresenius Medical by adding Fresenius Medical to a well-diversified portfolio.
Fresenius Medical Fundamentals Growth
Fresenius Stock prices reflect investors' perceptions of the future prospects and financial health of Fresenius Medical, and Fresenius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresenius Stock performance.
| Return On Equity | 0.0632 | ||||
| Return On Asset | 0.0316 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 23.63 B | ||||
| Shares Outstanding | 579.7 M | ||||
| Price To Earning | 6.53 X | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 0.70 X | ||||
| Revenue | 19.34 B | ||||
| Gross Profit | 4.91 B | ||||
| EBITDA | 3.21 B | ||||
| Net Income | 740.87 M | ||||
| Cash And Equivalents | 342.86 M | ||||
| Cash Per Share | 1.75 X | ||||
| Total Debt | 11 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 44.67 X | ||||
| Cash Flow From Operations | 2.39 B | ||||
| Earnings Per Share | 1.42 X | ||||
| Market Capitalization | 13.77 B | ||||
| Total Asset | 33.57 B | ||||
| Retained Earnings | 11.27 B | ||||
| Working Capital | 2.26 B | ||||
| Current Asset | 6.98 B | ||||
| Current Liabilities | 4.19 B | ||||
About Fresenius Medical Performance
Assessing Fresenius Medical's fundamental ratios provides investors with valuable insights into Fresenius Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fresenius Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 51.77 | 35.54 | |
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.02 | 0.03 | |
| Return On Equity | 0.04 | 0.07 |
Things to note about Fresenius Medical Care performance evaluation
Checking the ongoing alerts about Fresenius Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fresenius Medical Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fresenius Medical generated a negative expected return over the last 90 days | |
| Fresenius Medical is unlikely to experience financial distress in the next 2 years | |
| Fresenius Medical has a very strong financial position based on the latest SEC filings | |
| Latest headline from thelincolnianonline.com: Midwest Trust Co Makes New Investment in Fresenius Medical Care AG Co. KGaA FMS |
- Analyzing Fresenius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresenius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Fresenius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresenius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresenius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresenius Medical's stock. These opinions can provide insight into Fresenius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.